JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 47:101-103, doi:10.1016/j.jacc.2005.10.072
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braunwald, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braunwald, E.

Epilogue: What Do Clinicians Expect From Imagers?

Eugene Braunwald, MD, MACC*

TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.


Figure 1
View larger version (53K):

[in a new window]
 
Figure 1 Risk stratification in coronary disease. The standard risk stratification allocates subjects to low-, intermediate-, and high-risk categories. High risk is traditionally considered to be >2% per year. However, since such patients may also include those at very high annual risk (>15%), the latter deserve to be placed into a separate category. Identification of a very-high-risk category will require development of imaging techniques aimed at the detection of unstable coronary plaques.

 

Figure 2
View larger version (32K):

[in a new window]
 
Figure 2 Proposed algorithm for the detection of plaques likely to result in acute coronary syndromes. After the initial stratification into low-, intermediate-, and high-risk categories, using the Framingham risk score (FRS) and defined by the estimated event rate per year, identification of patients at very high risk will need development of tests that characterize vessel wall and identification of vulnerable plaques (VP), not simply luminal obstruction. Inter = intermediate; F/U = follow-up; V. = very; New Rx = new treatment modes.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.